MoonLake Immunotherapeutics (MLTX) Other Gross PP&E Adjustments (2022 - 2026)
MoonLake Immunotherapeutics' Other Gross PP&E Adjustments history spans 5 years, with the latest figure at -$1.9 million for Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 28.27% to -$1.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.9 million through Mar 2026, up 28.27% year-over-year, with the annual reading at -$1.6 million for FY2025, 46.41% up from the prior year.
- Other Gross PP&E Adjustments came in at -$1.9 million for Q1 2026, down from -$1.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$169422.0 in Q3 2023 to a low of -$3.7 million in Q1 2024.
- The 5-year median for Other Gross PP&E Adjustments is -$2.1 million (2025), against an average of -$2.0 million.
- Year-over-year, Other Gross PP&E Adjustments tumbled 1818.99% in 2024 and then surged 46.41% in 2025.
- MoonLake Immunotherapeutics' Other Gross PP&E Adjustments stood at -$282580.0 in 2022, then plummeted by 1184.05% to -$3.6 million in 2023, then increased by 19.47% to -$2.9 million in 2024, then soared by 46.41% to -$1.6 million in 2025, then fell by 18.58% to -$1.9 million in 2026.
- Per Business Quant, the three most recent readings for MLTX's Other Gross PP&E Adjustments are -$1.9 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.9 million (Q3 2025).